Asia-Pacific HLA Typing Transplant Diagnostics Services Market, By Technology (Molecular Assay Technologies and Non-Molecular Assay Technologies), Product & Service (Reagents & Consumables, Instruments, Software & Services), Application (Diagnostic, Research), End User (Independent Reference Laboratories, Hospitals & Transplant Centres and Research Laboratories & Academic Institutes), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2027
The HLA typing transplant diagnostics services market is expected to reach USD 256.36 billion by 2027 witnessing market growth at a rate of 9.8% in the forecast period of 2020 to 2027. Data Bridge Market Research report on HLA typing transplant diagnostics services market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecasted period while providing their impacts on the market’s growth.
HLA stands for human leukocyte antigen and HLA testing is done to check the compatibility of the donor’s bone marrow or blood with that of the patient receiving it. These HLA are found on our cells and our immune system uses them as markers to identify if there is any foreign cell in our body. For transplant, there needs to be a close match between the donor and the patient as it significantly reduces the risk which can rise, post transplantation.
Various technological advancements in HLA typing, growing number of organ and stem cell transplantation processes, rise in research funding and public private partnerships are the factors driving the growth of HLA typing transplant diagnostics services market. High cost of PCR and NGS equipment, inadequate medical reimbursement for transplantation process and a huge gap between organ donating and transplanting are the restraints for HLA typing transplant diagnostics services market in the above mentioned period.
Rising preference for serological analysis to genome based HLA analysis and growing penetration of diagnostics equipment development are the opportunities for HLA typing transplant diagnostics services market. Possibility of mismatch between donor and receiver due to high sequence variability and low public awareness about organ transplantation are the challenges for HLA typing transplant diagnostics services market.
This HLA typing transplant diagnostics services market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on HLA typing transplant diagnostics services market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
HLA Typing Transplant Diagnostics Services Market Scope and Market Size
The HLA typing transplant diagnostics services market is segmented on the basis of technology, product & service, application and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
On the basis of technology, the HLA typing transplant diagnostics services market has been segmented as molecular assay technologies and non-molecular assay technologies. Molecular assay technologies can be further segmented into PCR-based molecular assays and sequencing-based molecular assays. PCR-based molecular assays can be further sub-segmented into real-time PCR, sequence-specific primer-PCR, sequence-specific oligonucleotide-PCR and other PCR-based molecular assays. Sequencing-based molecular assays can be further sub-segmented into sanger sequencing, next-generation sequencing and other sequencing-based molecular assays.
- On the basis of product & service, the HLA typing transplant diagnostics services market has been segmented into reagents & consumables, instruments and software & services.
- On the basis of application, the HLA typing transplant diagnostics services market has been segmented into diagnostic and research. Diagnostic can be further segmented into antibody screening, chimerism monitoring and other applications.
- HLA typing transplant diagnostics services market has also been segmented on the basis of end user into independent reference laboratories, hospitals & transplant centres and research laboratories & academic institutes.
Asia-Pacific HLA Typing Transplant Diagnostics Services Market Country Level Analysis
Asia-Pacific HLA typing transplant diagnostics services market is analysed and market size, volume information is provided by country, technology, product & service, application and end user as referenced above.
The countries covered in the Asia-Pacific HLA typing transplant diagnostics services market report are Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines and rest of Asia-Pacific.
China and India will dominate the growth in Asia-Pacific HLA typing transplant diagnostics services market due to increasing population, better healthcare facilities as well as increase in public-private support to develop and research in HLA typing transplantation. These countries have also been seen as medical tourism destination due to the presence of its advanced medical treatments.
The country section of the HLA typing transplant diagnostics services market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
HLA typing transplant diagnostics services market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for HLA typing transplant diagnostics services market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the HLA typing transplant diagnostics services market. The data is available for historic period 2020-2027.
Competitive Landscape and HLA Typing Transplant Diagnostics Services Market Share Analysis
The HLA typing transplant diagnostics services market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to HLA typing transplant diagnostics services market.
The major players covered in the Asia-Pacific HLA typing transplant diagnostics services market report are Takara Bio, Fujirebio, Inc., TBG Diagnostics Ltd., Proimmune Ltd., Creative Biolabs, Histogenetics LLC, Admera Health, Quick Biology, The Sequencing Center and One Lambda among other domestic and global players. Market share data is available for Asia-Pacific (APAC) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Thermo Fisher has introduced a COVID-19 antibody assay which targets the transplant community. This antibody will help to detect multiple distinct antibodies and help to reduce false positives.
Customization Available : Asia-Pacific HLA Typing Transplant Diagnostics Services Market
Data Bridge Market Research is a leader in consulting and advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include production cost analysis, trade route analysis, price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), import export and grey area results data, literature review, consumer analysis and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.